Our Physicians
Medical Oncologists
Radiation Oncologists Surgical Oncologists Alice J. Cohen, M.D., F.A.C.P., is Director of [ top ]
[ top ] Elois Gwendolyn Rogers-Phillips, M.D., is an attending physician at Newark Beth Israel Medical Center and has a private hematology and oncology practice in Newark, NJ. Board certified in hematology and oncology, Dr. Rogers-Phillips received her bachelor’s degree in chemistry from Indiana University and her medical degree from Howard University College of Medicine. Dr. Rogers-Phillips completed her postgraduate training in internal medicine at Freedman’s Hospital, and went on to pursue fellowships in hematology at Yale New Haven Hospital and St. Michael’s Medical Center in Newark. She is a past president of the American Women’s Medical Association and a member of several medical societies, including the American Medical Association and the American Cancer Society. [ top ] Indu Sabnani, M.D., F.A.C.P., is an attending physician in the division of hematology and oncology at Newark Beth Israel Medical Center and is an associate director of the fellowship program in hematology. Board certified in internal medicine, medical oncology and hematology, Dr. Sabnani received her bachelor’s degree in medicine and surgery from S.S. Medical College, Awadesh Pratap Singh University in Rewa, India, and her medical degree in internal medicine from All India Institute of Medical Sciences in New Delhi, India. Dr. Sabnani received postgraduate training in internal medicine at All India Institute of Medical Sciences as well as the Tata Memorial Cancer Hospital in Bombay, India, and United Hospital Medical Center. She pursued a research fellowship at Memorial Sloan Kettering Cancer Center in New York, and the University of Medicine and Dentistry of New Jersey. Dr. Sabnani is a member of several professional societies and has a special interest in clinical research involving management of breast cancer and colon cancer. [ top ] Maya Shah, M.D., is an attending physician in the division of hematology and oncology at Newark Beth Israel Medical Center. Board certified in internal medicine, medical oncology, hematology and obstetrics and gynecology, Dr. Shah received her bachelor of science in medicine and surgery from B.J. Medical College and Civil Hospital, Ahmedabad, India, and went on to complete an internship in internal medicine and a residency in obstetrics and gynecology at Civil Hospital. In the U.S., she pursued a fellowship in hematology and oncology at Montefiore Medical Center, Albert Einstein College of Medicine in NY. [ top ] Amita Kalia-Sharma, M.D., is Associate Program Director of the Fellowship Program for Hematology and Oncology at Newark Beth Israel Medical Center. Board certified in internal medicine, hematology and oncology, Dr. Kalai-Sharma received her bachelor’s degree and medical degree from Guru Nanak Dev University in Amritsar, India. Dr. Kalia-Sharma completed her postgraduate training in internal medicine and completed a fellowship in hematology and oncology at Newark Beth Israel Medical Center. She is a member of the American Society of Hematology and the American Society of Clinical Oncology. [ top ] Susan Talbot, MD is a fellow of the Royal Australian College of Physicians, an associate member of the American Association for Cancer Research, a corresponding member of the Medical Oncology Group Australia, and a member of the American Society of Clinical Oncology. She received her medical degree from the University of Melbourne in Melbourne, Australia. Before coming to the U.S., Dr. Talbot completed an internship and residencies at the Royal Melbourne Hospital in Melbourne, and a medical oncology fellowship through the Victorian Oncology Training Program. Here, she completed a residency in Internal Medicine and a fellowship in Medical Oncology and Hematology at the College of Physicians and Surgeons of Columbia University, New York. During her fellowship and an additional postdoctoral year she focused on clinical and laboratory based research for the tumor subtypes of sarcoma and mesothelioma. [ top ] Maheshwari M. Desai, MD Prior to coming to Newark Beth Israel Medical Center, Dr. Desai was the acting director of radiation oncology and an associate attending physician at Saint Vincent Catholic Medical Centers of Brooklyn and Queens in Jamaica, New York. [ top ]
Dr. Ivker has made clinical research and patient access to state-of-the-art cancer treatments his highest priority. The Department of Radiation Oncology at Newark Beth Israel is one of a select few in the state of New Jersey that is affiliated with the Radiation Therapy Oncology Group (RTOG) through its relationship with Thomas Jefferson University. Due to this affiliation the department has access to the most up to date and most promising "cutting edge" treatment protocols, designed to explore new methods of treatment. The goal of these protocols is simple, increase the chance of cure while reducing the risk of side effects. Dr. Ivker is a member of The American Society for Therapeutic Radiology and Oncology (ASTRO), American College of Radiation Oncology (ACRO), as well as other professional societies. He has and continues to present his work on head and neck, breast, and prostate cancer at national and international meetings. Recently, a chapter on gastrointestinal malignancies (gastric and pancreas) that Dr. Ivker co-authored was published in a textbook for other physicians. He is Board certified by the American Board of Radiology for the practice of Radiation Oncology and is consistently recognized as performing "the first of its kind" procedures in the state. Caring nursing and dedicated healthcare professionals round out a compassionate, multidisciplinary team approach to cancer patients and their families. [ top ]
Dr. Wascher brings extensive clinical and research expertise in the comprehensive surgical management of cancer to Newark Beth Israel Medical Center. Working closely with other clinical oncology specialists at the Beth, Dr. Wascher's emphasis on minimally invasive approaches to the treatment of many cancers adds significantly to the already wide range of adult oncology services provided by the Frederick B. Cohen Comprehensive Cancer Center. Dr. Wascher received his bachelor’s degree in Biological Sciences (Honors in Research) from the University of California at Irvine, and his medical degree (magna cum laude) from the Creighton University School of Medicine in Omaha, NE. He completed a surgical internship at Letterman Army Medical Center in San Francisco, CA; a neurosurgery fellowship at Brooke Army Medical Center in San Antonio, TX; a surgical residency at Tripler Army Medical Center in Honolulu, HI; and a fellowship in Surgical Oncology and Molecular Oncology at the John Wayne Cancer Institute in Santa Monica, CA. Dr. Wascher is a Fellow of the Society of Surgical Oncology, the American Society of Clinical Oncology, and the American College of Surgeons. He is a longstanding member the American Medical Association, the American Association for the Advancement of Science, the Authors Guild, and the National Institutes of Health Community Clinical Oncology Program. Dr. Wascher has served as principal investigator and co-investigator for multiple leading national and international clinical cancer trials, and he has a special interest in ethnic variations in cancer biology and epidemiology, as well as cancer prevention strategies at the molecular level. [ top ] |
|
||||||


the Division of Hematology and Oncology, Newark Beth Israel Medical Center and oversees the Flo Okin Oncology and Blood Disorders Center and the Comprehensive Hemophilia Treatment Center. Board certified in internal medicine, hematology and oncology, Dr. Cohen received her bachelor’s degree from Bryn Mawr College in Pennsylvania and her medical degree from Chicago Medical School in Illinois. Dr. Cohen completed her postgraduate training in internal medicine at New York University and completed research fellowships in hematology and oncology at George Washington University Medical Center in Washington, D.C. and Columbia Presbyterian Medical Center in New York. She is an Associate Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons. Dr. Cohen is an investigator for the National Surgical Adjuvant Breast and Bowel Project. 



